Life sciences secures £2.45bn investment in golden triangle during 2022

Life science lab

Source: Shutterstock/Matej Kastelic

Investment into life sciences real estate exceeded £2.45bn in the ‘golden triangle’ in 2022, according to a report from Cushman & Wakefield.

The firm’s Life Sciences Golden Triangle Lab Report showed that demand for purpose-built life sciences space in Cambridge, Oxford and London, also known as the golden triangle, remained “extremely strong” in 2022 despite supply shortages.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.

Registered users and subscribers SIGN IN here to continue